Your browser doesn't support javascript.
loading
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study.
Platzbecker, Uwe; Götze, Katharina S; Kiewe, Philipp; Germing, Ulrich; Mayer, Karin; Radsak, Markus; Wolff, Thomas; Chromik, Joerg; Sockel, Katja; Oelschlägel, Uta; Haase, Detlef; Illmer, Thomas; Al-Ali, Haifa Kathrin; Silling, Gerda; Reynolds, Joseph G; Zhang, Xiaosha; Attie, Kenneth M; Shetty, Jeevan K; Giagounidis, Aristoteles.
Afiliación
  • Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.
  • Götze KS; Department of Medicine III, Hematology and Medical Oncology, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.
  • Kiewe P; Onkologischer Schwerpunkt am Oskar-Helene-Heim, Berlin, Germany.
  • Germing U; Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
  • Mayer K; Department of Internal Medicine III, University Hospital Bonn, Bonn, Germany.
  • Radsak M; Johannes Gutenberg Universität Mainz, Mainz, Germany.
  • Wolff T; OncoResearch Lerchenfeld UG, Hamburg, Germany.
  • Chromik J; Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt/Main, Germany.
  • Sockel K; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Oelschlägel U; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Haase D; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Illmer T; Hematology Private Practice, Dresden, Germany.
  • Al-Ali HK; Department of Hematology/Oncology, University Hospital Halle, Halle, Germany.
  • Silling G; Krukenberg Cancer Center Halle, University Hospital Halle, Halle, Germany.
  • Reynolds JG; Department of Hematology and Oncology, University of Aachen, Aachen, Germany.
  • Zhang X; Formerly Acceleron Pharma, Inc, Cambridge, MA.
  • Attie KM; Formerly Acceleron Pharma, Inc, Cambridge, MA.
  • Shetty JK; Formerly Acceleron Pharma, Inc, Cambridge, MA.
  • Giagounidis A; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland.
J Clin Oncol ; 40(33): 3800-3807, 2022 11 20.
Article en En | MEDLINE | ID: mdl-35998303
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Eritropoyetina / Anemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Eritropoyetina / Anemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos